Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Enterprise Value (2021 - 2025)

Bioregenx (BRGX) has 5 years of Enterprise Value data on record, last reported at -$46947.0 in Q3 2025.

  • For Q3 2025, Enterprise Value rose 33.01% year-over-year to -$46947.0; the TTM value through Sep 2025 reached -$46947.0, up 33.01%, while the annual FY2024 figure was -$58404.0, 53.43% up from the prior year.
  • Enterprise Value reached -$46947.0 in Q3 2025 per BRGX's latest filing, down from -$46456.0 in the prior quarter.
  • Across five years, Enterprise Value topped out at -$676.0 in Q4 2022 and bottomed at -$125402.0 in Q4 2023.
  • Average Enterprise Value over 5 years is -$45383.0, with a median of -$46701.5 recorded in 2025.
  • Peak YoY movement for Enterprise Value: surged 97.22% in 2022, then tumbled 18450.59% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$24358.0 in 2021, then soared by 97.22% to -$676.0 in 2022, then crashed by 18450.59% to -$125402.0 in 2023, then skyrocketed by 53.43% to -$58404.0 in 2024, then rose by 19.62% to -$46947.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$46947.0 in Q3 2025, -$46456.0 in Q2 2025, and -$83625.0 in Q1 2025.